Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.037 | 0.1736 | 0.1736 |
Plasmodium vivax | cation/H+ antiporter, putative | 0.0049 | 0.0055 | 1 |
Brugia malayi | Na/Ca eXchangers family member (ncx-4) | 0.0049 | 0.0055 | 0.0143 |
Toxoplasma gondii | manganese resistance 1 protein, putative | 0.0049 | 0.0055 | 1 |
Brugia malayi | Sodium/calcium exchanger protein | 0.0779 | 0.3879 | 1 |
Mycobacterium ulcerans | beta-lactamase | 0.0039 | 0 | 0.5 |
Trichomonas vaginalis | alpha-L-fucosidase, putative | 0.0344 | 0.1597 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0049 | 0.0055 | 0.0055 |
Echinococcus granulosus | sodium:potassium:calcium exchanger | 0.0049 | 0.0055 | 0.0055 |
Schistosoma mansoni | sodium/calcium exchanger | 0.1948 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0055 | 0.0055 |
Echinococcus multilocularis | geminin | 0.037 | 0.1736 | 0.1736 |
Schistosoma mansoni | na/ca exchanger | 0.0049 | 0.0055 | 0.0055 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0039 | 0 | 0.5 |
Loa Loa (eye worm) | solute carrier family 8 | 0.1948 | 1 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0039 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0049 | 0.0055 | 0.0347 |
Schistosoma mansoni | potassium-dependent sodium-calcium exchanger 3 4 | 0.0049 | 0.0055 | 0.0055 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0039 | 0 | 0.5 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0247 | 0.1089 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0055 | 0.0055 |
Schistosoma mansoni | hypothetical protein | 0.037 | 0.1736 | 0.1736 |
Brugia malayi | K+-dependent Na+/Ca+ exchanger related-protein | 0.0049 | 0.0055 | 0.0143 |
Echinococcus granulosus | sodium:potassium:calcium exchanger 6 | 0.0049 | 0.0055 | 0.0055 |
Schistosoma mansoni | potassium-dependent sodium-calcium exchanger 3 4 | 0.0049 | 0.0055 | 0.0055 |
Mycobacterium leprae | Probable ionic transporter integral membrane protein ChaA | 0.0049 | 0.0055 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0049 | 0.0055 | 0.0347 |
Mycobacterium tuberculosis | Probable ionic transporter integral membrane protein ChaA | 0.0049 | 0.0055 | 0.0508 |
Echinococcus multilocularis | sodium:potassium:calcium exchanger | 0.0049 | 0.0055 | 0.0055 |
Entamoeba histolytica | sodium/calcium exchanger protein, putative | 0.0049 | 0.0055 | 0.5 |
Echinococcus multilocularis | sodium:potassium:calcium exchanger 6 | 0.0049 | 0.0055 | 0.0055 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0039 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0039 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0779 | 0.3879 | 0.3879 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0049 | 0.0055 | 0.0347 |
Mycobacterium ulcerans | hypothetical protein | 0.0039 | 0 | 0.5 |
Treponema pallidum | hypothetical protein | 0.0049 | 0.0055 | 0.5 |
Plasmodium falciparum | cation/H+ antiporter | 0.0049 | 0.0055 | 0.5 |
Trichomonas vaginalis | alpha-L-fucosidase, putative | 0.0344 | 0.1597 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0039 | 0 | 0.5 |
Onchocerca volvulus | Sodium\/potassium\/calcium exchanger | 0.0049 | 0.0055 | 1 |
Echinococcus granulosus | geminin | 0.037 | 0.1736 | 0.1736 |
Mycobacterium ulcerans | lipase LipD | 0.0039 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0055 | 0.0055 |
Loa Loa (eye worm) | Na/Ca eXchangers family member | 0.0049 | 0.0055 | 0.0055 |
Echinococcus multilocularis | sodium calcium exchanger | 0.1948 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -4.412 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.188 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.176 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.